3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile
|
|
|
- CAS-Nr.
- 1092578-48-7
- Englisch Name:
- 3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile
- Synonyma:
- Tofacitinib-16;(3S,4R)-Tofacitinib;Tofatinib Impurity B;Tofacitinib Impurity 228;Tofacitinib Impurity FD+DX;YYMGYZDHOQYMFO-DGCLKSJQSA-N;Tofacitinib Impurity B(3S,4R);Azilsartan medoxomil impurity338;Tofacitinib Impurity B (3S,4R)-Tofacitinib;(3S,4R)-Tofacitinib (Tofacitinib Impurity)
- CBNumber:
- CB32642728
- Summenformel:
- C16H20N6O
- Molgewicht:
- 312.3696
- MOL-Datei:
- 1092578-48-7.mol
|
3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile Eigenschaften
- Dichte
- 1.296
- storage temp.
- Store at -20°C
- L?slichkeit
- Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc.
- Aggregatzustand
- Powder
- pka
- 6.04±0.60(Predicted)
Sicherheit
3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
(3S,4R)-Tofacitinib is an enantiopure stereoisomer of the drug, Janus kinase 3(Jak3) inhibitor (CP-690,550) that has been found to inhibit selected members of the STE7 and STE20 subfamily of kinases.
3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 94)Lieferanten
1092578-48-7()Verwandte Suche:
- 3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile
- (3S,4R)-4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-beta-oxo-1-piperidinepropanenitrile
- (3S,4R)-Tofacitinib
- 1-Piperidinepropanenitrile, 4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-β-oxo-, (3S,4R)-
- Tofacitinib Impurity B(3S,4R)
- YYMGYZDHOQYMFO-DGCLKSJQSA-N
- (3S,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-1-piperidinepropanenitrile
- Tofacitinib Impurity FD+DX
- Tofacitinib Impurity B (3S,4R)-Tofacitinib
- Tofacitinib-16
- Tofacitinib impurity 12/(3S,4R)-Tofacitinib/3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile
- Azilsartan medoxomil impurity338
- 3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitr
- Tofatinib Impurity B
- Tofacitinib Impurity 228
- 1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (3S,4R)-
- (3S,4R)-Tofacitinib (Tofacitinib Impurity)
- 1092578-48-7
- GYL
